496
Views
154
CrossRef citations to date
0
Altmetric
Review

Epidemiology and treatment of post-stroke depression

Pages 145-154 | Published online: 08 Feb 2008

References

  • AbenIVerheyFStrikJA comparative study into the one year cumulative incidence of depression after stroke and myocardial infarctionJ Neurol Neurosurg Psychiatry200374581512700297
  • AlexopoulosGS“The depression-executive dysfunction syndrome of late life”: a specific target for D3 agonists?Am J Geriatr Psychiatry2001922911156748
  • AlexopoulosGSThe vascular depression hypothesis: 10 years laterBiol Psychiatry2006601304517157096
  • AlexopoulosGSMeyersBSYoungRC‘Vascular depression’ hypothesisArch Gen Psychiatry1997a54915229337771
  • AlexopoulosGSMeyersBSYoungRCClinically defined vascular depressionAm J Psychiatry1997b15456259090349
  • AlmeidaOPWaterreusAHankeyGJPreventing depression after stroke: Results from a randomized placebo-controlled trialJ Clin Psychiatry2006671104916889454
  • AndersenGVestergaardKLauritzenLEffective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopramStroke1994a2510991048202964
  • AndersenGVestergaardKRiisJIncidence of post-stroke depression during the first year in a large unselected stroke population determined using a valid standardized rating scaleActa Psychiatr Scand1994b9019057810342
  • AndersonCHackettMHouseAInterventions for preventing depression after strokeCochrane Database Syst Rev20042CD00368915106212
  • BakSTsiropoulosIKjaersgaardJOSelective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control studyStroke20023314657312052976
  • BakishDNew standard of depression treatment: remission and full recoveryJ Clin Psychiatry200162Suppl 265911775091
  • BergAPalomakiHLehtihalmesMPoststroke depression in acute phase after strokeCerebrovasc Dis200112142011435674
  • BhogalSKTeasellRFoleyNHeterocyclics and selective serotonin reuptake inhibitors in the treatment and prevention of poststroke depressionJ Am Geriatr Soc2005531051715935033
  • BrodatyHWithallAAltendorfARates of depression at 3 and 15 months poststroke and their relationship with cognitive decline: the Sydney Stroke StudyAm J Geriatr Psychiatry2007154778617545448
  • CarsonAJMacHaleSAllenKDepression after stroke and lesion location: a systematic reviewLancet2000356122610963248
  • ChemerinskiERobinsonRGKosierJTImproved recovery in activities of daily living associated with remission of poststroke depressionStroke2001321131711136924
  • ChenYGuoJJMeta-analysis of antidepressant treatment for patients with poststroke depressionStroke2006371365616645130
  • ChenYPatelNCGuoJJAntidepressant prophylaxis for poststroke depression: a meta-analysisInt Clin Psychopharmacol2007221596617414742
  • Choi-KwonSHanSWKwonSUFluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness: a double-blind, placebo-controlled studyStroke2006371566116306470
  • DahmenNMarxJHopfHCTherapy of early poststroke depression with venlafaxine: safety, tolerability, and efficacy as determined in an open, uncontrolled clinical trialStroke199930691210066874
  • DamMToninPDe BoniAEffects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapyStroke1996271211148685930
  • DamecourCLCaplanDThe relationship of depression to symptomatology and lesion site in aphasic patientsCortex1991273854011743034
  • de AbajoFJJickHDerbyLIntracranial haemorrhage and use of selective serotonin reuptake inhibitorsBr J Clin Pharmacol20005043710886117
  • FedoroffJPRobinsonRGTricyclic antidepressants in the treatment of poststroke depressionJ Clin Psychiatry198950Suppl18232661548
  • FedoroffJPStarksteinSEParikhRMAre depressive symptoms nonspecific in patients with acute stroke?Am J Psychiatry1991148117261882994
  • FruehwaldSGatterbauerERehakPEarly fluoxetine treatment of post-stroke depression A three-month double-blind placebo-controlled study with an open-label long-term follow upJ Neurol20032503475112638027
  • GainottiGAntonucciGMarraCRelation between depression after stroke, antidepressant therapy, and functional recoveryJ Neurol Neurosurg Psychiatry2001712586111459907
  • GillDHatcherSA systematic review of the treatment of depression with antidepressant drugs in patients who also have a physical illnessJ Psychosom Res1999471314310579497
  • GillenRTennenHMcKeeTEDepressive symptoms and history of depression predict rehabilitation efficiency in stroke patientsArch Phys Med Rehabil2001821645911733876
  • Gonzalez-TorrecillasJLMendlewiczJLoboAEffects of early treatment of poststroke depression on neuropsychological rehabilitationInt Psychogeriatr19957547608833278
  • GordonWAHibbardMRPoststroke depression: an examination of the literatureArch Phys Med Rehabil199778658639196475
  • GustafsonYNilssonIMattssonMEpidemiology and treatment of post-stroke depressionDrugs Aging199572983098535057
  • HackettMLAndersonCSHouseAOInterventions for treating depression after strokeCochrane Database Syst Rev2004CD00343715266484
  • HackettMLAndersonCSHouseAOManagement of depression after stroke: a systematic review of pharmacological therapiesStroke2005a36109810315802637
  • HackettMLYapaCParagVFrequency of depression after stroke: a systematic review of observational studiesStroke2005b3613304015879342
  • HemeryckABelpaireFMSelective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an updateCurr Drug Metab20023133711876575
  • HerrmannNBlackSELawrenceJThe Sunnybrook Stroke Study: a prospective study of depressive symptoms and functional outcomeStroke199829618249506602
  • HickieIScottEMitchellPSubcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depressionBiol Psychiatry199537151607727623
  • HouseADennisMHawtonKMethods of identifying mood disorders in stroke patients: experience in the Oxfordshire Community Stroke ProjectAge Ageing19891837192629484
  • HouseAKnappPBamfordJMortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 monthStroke20013269670111239189
  • JorgeRERobinsonRGArndtSMortality and poststroke depression: a placebo-controlled trial of antidepressantsAm J Psychiatry20031601823914514497
  • JorgensenLEngstadTJacobsenBKHigher incidence of falls in long-term stroke survivors than in population controls: depressive symptoms predict falls after strokeStroke200233542711823667
  • KauhanenMKorpelainenJTHiltunenPPoststroke depression correlates with cognitive impairment and neurological deficitsStroke19993018758010471439
  • KauhanenMLKorpelainenJTHiltunenPAphasia, depression, and non-verbal cognitive impairment in ischaemic strokeCerebrovasc Dis2000104556111070376
  • KellermannMFeketeIGesztelyiRScreening for depressive symptoms in the acute phase of strokeGen Hosp Psychiatry1999211162110228892
  • KimPWarrenSMadillHQuality of life of stroke survivorsQual Life Res1999829330110472161
  • KingRBQuality of life after strokeStroke1996271467728784114
  • KneeboneIIDunmoreEPsychological management of post-stroke depressionBr J Clin Psychol200039Pt 1536510789028
  • KotilaMNumminenHWaltimoOPost-stroke depression and functional recovery in a population-based stroke register. The Finnstroke studyEur J Neurol199963091210210911
  • LaskaACMartenssonBKahanTRecognition of Depression in Aphasic Stroke PatientsCerebrovasc Dis20072474917519547
  • LauritzenLBendsenBBVilmarTPost-stroke depression: combined treatment with imipramine or desipramine and mianserin. A controlled clinical studyPsychopharmacology (Berl)1994114119227846193
  • LincolnNBFlannaghanTCognitive behavioral psychotherapy for depression following stroke: a randomized controlled trialStroke2003341111512511760
  • LincolnNBFlannaghanTSutcliffeLEvaluation of cognitive behavioural treatment for depression after stroke: a pilot studyClin Rehabil199711114229199863
  • LindenTBlomstrandCSkoogIDepressive disorders after 20 months in elderly stroke patients. A case-control studyStroke2007381860317431211
  • LipseyJRRobinsonRGNortriptyline for post-stroke depressionLancet198418036143131
  • LoubinouxIParienteJBoulanouarKA single dose of the serotonin neurotransmission agonist paroxetine enhances motor output: Double-blind, placebo-controlled, fMRI study in healthy subjectsNeuroimage200215263611771971
  • MastBTMacNeillSELichtenbergPAPost-stroke and clinically-defined vascular depression in geriatric rehabilitation patientsAm J Geriatr Psychiatry200412849214729563
  • Maurer-SpurejEPittendreighCSolomonsKThe influence of selective serotonin reuptake inhibitors on human platelet serotoninThromb Haemost2004911192814691577
  • MiyaiIRedingMJEffects of antidepressants on functional recovery following stroke: a double-blind studyJ Neuro Rehab199812513
  • MorrisPLRobinsonRGAndrzejewskiPAssociation of depression with 10-year poststroke mortalityAm J Psychiatry199315012498417554
  • MurrayVvon ArbinMBartfaiADouble-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depressionJ Clin Psychiatry2005667081615960563
  • NeauJPIngrandPMouille-BrachetCFunctional recovery and social outcome after cerebral infarction in young adultsCerebrovasc Dis199882963029712928
  • PaolucciSAntonucciGGrassoMGPost-stroke depression, antidepressant treatment and rehabilitation results. A case-control studyCerebrovasc Dis2001122647111641594
  • PaolucciSAntonucciGPratesiLPoststroke depression and its role in rehabilitation of inpatientsArch Phys Med Rehabil1999809859010488996
  • PaolucciSGandolfoCProvincialiLon behalf of DESTRO Study GroupThe Italian multicenter observational study on post-stroke depression (DESTRO)J Neurol20062535566216767539
  • ParienteJLoubinouxICarelCFluoxetine modulates motor performance and cerebral activation of patients recovering from strokeAnn Neurol2001507182911761469
  • PohjasvaaraTVatajaRLeppavuoriADepression is an independent predictor of poor long-term functional outcome post-strokeEur J Neurol200183151911422427
  • RamasubbuRCerebrovascular effects of selective serotonin reuptake inhibitors: a systematic reviewJ Clin Psychiatry20046516425315641869
  • RamasubbuRRobinsonRGFlintAJFunctional impairment associated with acute poststroke depression: the Stroke Data Bank StudyJ Neuropsychiatry Clin Neurosci19981026339547463
  • RampelloLChiechioSNicolettiGPrediction of the response to citalopram and reboxetine in post-stroke depressed patientsPsychopharmacology (Berl)200417373814685645
  • RedingMJOrtoLAWinterSWAntidepressant therapy after stroke. A double-blind trialArch Neurol19864376353729755
  • RobinsonRGSchultzSKCastilloCNortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind studyAm J Psychiatry2000157351910698809
  • SartiCRastenyteDCepaitisZInternational trends in mortality from stroke, 1968 to 1994Stroke200031158860110884459
  • SchubertDSTaylorCLeeSDetection of depression in the stroke patientPsychosomatics19923329041410202
  • SchulzRBeachSRIvesDGAssociation between depression and mortality in older adults: the Cardiovascular Health StudyArch Intern Med20001601761810871968
  • SchwartzJASpeedNMBrunbergJADepression in stroke rehabilitationBiol Psychiatry19933369498353164
  • SimpsonSBaldwinRCJacksonAIs subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depressionPsychol Med1998281015269794009
  • SinyorDAmatoPKaloupekDGPost-stroke depression: relationships to functional impairment, coping strategies, and rehabilitation outcomeStroke198617110273810708
  • SkopBPBrownTMPotential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitorsPsychosomatics1996371268600488
  • [SPREAD] Stroke Prevention and Educational Awareness DiffusionComplicanze psico-cognitive dell’ictus. In Ictus cerebrale: linee guida italiane di prevenzione e trattamento2005MilanoPubblicazioni Catel – Hyperphar Group SpAp43579
  • TaylorWDSteffensDCKrishnanKRPsychiatric disease in the twenty-first century: The case for subcortical ischemic depressionBiol Psychiatry200660129930317014829
  • TownendBSWhyteSDesboroughTLongitudinal prevalence and determinants of early mood disorder post-strokeJ Clin Neurosci2007144293417336529
  • Turner-StokesLHassanNDepression after stroke: a review of the evidence base to inform the development of an integrated care pathway. Part 2: Treatment alternativesClin Rehabil2002162486012017512
  • van de WegFBKuikDJLankhorstGJPost-stroke depression and functional outcome: a cohort study investigating the influence of depression on functional recovery from strokeClin Rehabil1999132687210392654
  • Van deMHGeurtsACVan LimbeekJPharmacologic treatment of poststroke depression: a systematic review of the literatureTop Stroke Rehabil200310799212970833
  • VatajaRLeppavuoriAPohjasvaaraTPoststroke depression and lesion location revisitedJ Neuropsychiatry Clin Neurosci2004161566215260366
  • VerdelhoAHenonHLebertFDepressive symptoms after stroke and relationship with dementia: A three-year follow-up studyNeurology2004629051115037691
  • WiartLPetitHJosephPAFluoxetine in early poststroke depression: a double-blind placebo-controlled studyStroke20003118293210926942
  • WilliamsLSGhoseSSSwindleRWDepression and other mental health diagnoses increase mortality risk after ischemic strokeAm J Psychiatry20041611090515169698
  • WindleVCorbettDFluoxetine and recovery of motor function after focal ischemia in ratsBrain Res20051044253215862786
  • YamakawaYSatohSSawaSEfficacy of milnacipran on poststroke depression on inpatient rehabilitationPsychiatry Clin Neurosci2005597051016401247